Concurrent inhibition of p300/CBP and FLT3 enhances cytotoxicity and overcomes resistance in acute myeloid leukemia
Yujun Chen(ShanghaiTech University), Chengying Xie(CNH Industrial (Czechia))
Cited by 5
Related Papers
Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor‐2 inhibitor
|Cancer Science|2018|368
Pharmacological characterization of hetrombopag, a novel orally active human thrombopoietin receptor agonist
|Journal of Cellular and Molecular Medicine|2018|59